A U.S. trial of a fully implanted hearing device hits six months of follow-up. Envoy Medical says it may be first.
Envoy has submitted 2 of 4 planned FDA modules and expects to submit its final trial-data module by end-Q2 2027; 12-month visits are on track for early Q2.
